Jun Takizawa
Overview
Explore the profile of Jun Takizawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
705
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shimada K, Yamaguchi M, Kuwatsuka Y, Matsue K, Sato K, Kusumoto S, et al.
EClinicalMedicine
. 2025 Feb;
80:103078.
PMID: 39968389
Background: Intravascular large B-cell lymphoma (IVLBCL) is a rare type of extranodal large B-cell lymphoma for which prognosis is typically poor without a timely diagnosis. To explore the safety and...
2.
Fujimoto A, Miyazaki K, Yakushijin K, Fujino T, Munakata W, Ejima Y, et al.
Leukemia
. 2025 Feb;
PMID: 39962328
A retrospective study of extranodal natural killer/T-cell lymphoma (ENKL) patients diagnosed between 2014 and 2021 in Japan was conducted. Among 351 patients with sufficient data, 116 (33%) were in the...
3.
Nato Y, Miyazaki K, Maruyama D, Takahashi H, Sunami K, Murakami S, et al.
Hematol Oncol
. 2025 Feb;
43(2):e70047.
PMID: 39937961
CD5-positive diffuse large B-cell lymphoma (CD5+ DLBCL) is characterized by a poor prognosis and frequent central nervous system (CNS) relapse. Sandwich therapy comprising dose-adjusted (DA)-EPOCH-R (etoposide, prednisolone, vincristine, cyclophosphamide, doxorubicin,...
4.
Muta T, Masamoto Y, Yamamoto G, Kurahashi S, Kameoka Y, Ota S, et al.
Int J Hematol
. 2024 Nov;
121(2):161-173.
PMID: 39586984
Ibrutinib is a first-in-class Bruton's tyrosine kinase inhibitor that is approved for the treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in Japan based on randomized clinical trial data....
5.
Pinyomahakul J, Ise M, Kawamura M, Yamada T, Okuyama K, Shibata S, et al.
Int J Mol Sci
. 2024 Jul;
25(14).
PMID: 39063018
The gene encodes a lipid transfer protein called VPS13A, or chorein, associated with mitochondria-associated endoplasmic reticulum (ER) membranes (MAMs), mitochondria-endosomes, and lipid droplets. This protein plays a crucial role in...
6.
Yamaguchi M, Fukuhara N, Takizawa J, Ishitsuka K, Yokohama A, Miyazaki K, et al.
J Clin Exp Hematop
. 2024 Jul;
64(3):216-222.
PMID: 38960696
Alemtuzumab is recommended as first-line and second-line therapies for T-cell prolymphocytic leukemia (T-PLL). This study retrospectively evaluated the efficacy and safety of alemtuzumab in nine Japanese patients with T-PLL at...
7.
Takizawa J, Teshima T, Ennishi D, Ichikawa S, Suzuki R, Kojima A, et al.
Leuk Lymphoma
. 2024 Jul;
65(11):1586-1594.
PMID: 38952054
This report focuses on part 3 of a multicenter, open-label, phase 1 study (NCT03198650) assessing the safety, pharmacokinetics (PK), pharmacodynamics (PD), and antitumor activity of acalabrutinib plus obinutuzumab in Japanese...
8.
Natsumeda M, Shibuma S, Takahashi H, On J, Mouri Y, Tomikawa K, et al.
Brain Tumor Pathol
. 2024 Apr;
41(2):85-91.
PMID: 38597999
Surgical biopsy is the gold standard for diagnosing central nervous system (CNS) lymphomas. However, reliable liquid biopsy methods for diagnosing CNS lymphomas have quickly developed and have been implicated in...
9.
Mori Y, Takizawa J, Katsuoka Y, Takezako N, Nagafuji K, Handa H, et al.
Cancer Sci
. 2024 Mar;
115(6):2002-2011.
PMID: 38498976
Triplet regimen comprising proteasome inhibitors, immunomodulatory drugs, and dexamethasone (DEX) is a recommended induction/consolidation therapy for multiple myeloma (MM) patients eligible for transplant. In this Japanese phase II study conducted...
10.
Takizawa J, Suzuki R, Izutsu K, Kiguchi T, Asaoku H, Saburi Y, et al.
Int J Hematol
. 2024 Mar;
119(6):686-696.
PMID: 38492198
Chronic lymphocytic leukemia (CLL) is rare in Japan. We conducted the nationwide, prospective observational study CLLRSG-01 to clarify the current state of CLL in Japan and to make accurate international...